Stocklytics Platform
Asset logo for symbol COYA
Coya Therapeutics
COYA47
$5.65arrow_drop_down3.51%-$0.20
Asset logo for symbol COYA
COYA47

$5.65

arrow_drop_down3.51%

Income Statement (COYA)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$4.45M-$3.23M-$5.48M$1.81M-$3.56M
EBITDA-$4.44M-$3.22M-$5.48M$1.82M-$3.55M
gross Profit-$6,841.00$3.41M$119.99K$5.99M-$6,841.00
NET Income-$4.02M-$2.89M-$5.05M$1.26M-$3.42M
total Revenue$0.00$3.42M$126.83K$6.00M$0.00

Balance Sheet (COYA)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$31.05M-$36.57M-$35.98M-$32.62M-$10.88M
stockholders Equity$32.01M$35.25M$32.54M$35.64M$10.08M
total Assets$35.55M$39.93M$37.54M$41.27M$11.89M
total Debt-----
total Liabilities$3.54M$4.68M$5.00M$5.62M$1.80M

Cash Flow (COYA)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$56.33K$5.14M$1.24M$24.17M$0.00
free Cash Flow-$5.46M-$4.56M$2.12M-$2.24M-$2.21M
investing Cash Flow-----
operating Cash Flow-$5.46M-$4.56M$2.14M-$2.24M-$2.21M

Coya Therapeutics (COYA) Financials

COYA Therapeutics, Inc. (COYA) is a biotechnology company focused on developing innovative therapies for various diseases. The company's financials are an important aspect of assessing its performance and growth potential. The income statement provides a summary of COYA's revenues, expenses, and net income. It shows how much money the company generated from its operations and how it utilized those funds. The EBIT (Earnings Before Interest and Taxes) is a measure of COYA's operating profitability, excluding the impact of interest and taxes. It gives investors an idea of the company's ability to generate profits from its core operations. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is another profitability metric that provides a clearer picture of COYA's operating performance by eliminating the effects of non-cash expenses. Gross profit represents the revenue remaining after deducting the cost of goods sold. It indicates the company's ability to generate sales at a profitable margin.
Net income from stockholders reflects the final profitability after all expenses, taxes, and interest payments have been accounted for. It represents the amount of money available to be distributed to stockholders or reinvested in the business. Total revenue encompasses all the money earned by COYA from its operations, including sales of products or services. The balance sheet provides a snapshot of COYA's financial position at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. Cash equivalents are highly liquid assets that can be easily converted into cash. They help ensure COYA's ability to meet its short-term obligations. Net debt is the difference between a company's total debt and its cash and cash equivalents. Stockholders' equity represents the residual interest in the assets of the company after deducting liabilities. It is an important measure of COYA's financial health. Total assets are the sum of all tangible and intangible assets that COYA owns. Total debt includes all financial obligations that COYA has, including both short-term and long-term liabilities. Total liabilities encompass all the financial obligations that COYA has, including both current and long-term liabilities.
Cash flow refers to the movement of cash into and out of COYA's business. It is a crucial indicator of the company's ability to generate cash and its financial flexibility. Financing cash flow represents the cash flow resulting from COYA's financing activities, such as issuing or repurchasing stock, paying dividends, or obtaining or repaying debt. Free cash flow is the cash generated by COYA's operations after deducting capital expenditures. It is an important measure of the company's ability to generate excess cash for growth and debt reduction. Investing cash flow represents the cash flow resulting from COYA's investing activities, such as acquiring or disposing of assets. Operating cash flow represents the cash flow resulting from COYA's core business operations, excluding financing and investing activities. It shows how well the company generates cash from its operations.
add Coya Therapeutics to watchlist

Keep an eye on Coya Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level